Literature DB >> 11160949

Emotional conversations in Parkinson's disease.

G P Crucian1, L Huang, A M Barrett, R L Schwartz, J E Cibula, J M Anderson, W J Triggs, D Bowers, W A Friedman, M Greer, K M Heilman.   

Abstract

OBJECTIVE: To learn how PD influences verbal description of emotional events.
BACKGROUND: Individuals with PD exhibit emotional processing deficits. Emotional experience likely involves several dimensions (e.g., valence, arousal, motor activation) subserved by a distributed modular network involving cortical, limbic, basal ganglia, diencephalic, and mesencephalic regions. Although the neurodegeneration in PD likely affects components in this network, little is known about how PD influences emotional processing. Because PD is associated with activation deficits, one could predict that the discourse of emotional experiences involving high activation would be reduced in patients with PD compared to control subjects. Alternatively, because patients with PD exhibit paradoxical sensitivity to externally evoked motor activation (kinesia paradoxica), it is possible that emotional stimuli may facilitate verbal emotional expression more so in patients with PD than in control subjects.
METHODS: The authors measured verbal descriptions of personal emotional experiences in subjects with PD and normal controls.
RESULTS: Compared with control subjects, individuals with PD showed a relative increase in the number of words spoken and in discourse duration when talking about emotional experiences that are usually associated with high levels of arousal and motor activation. Although the authors did not measure arousal or activation, prior research has shown that, when asked to recall an emotional experience, people will often re-experience the emotion previously experienced during that episode.
CONCLUSIONS: Recalling emotional episodes induces verbal kinesia paradoxica in patients with PD. Although recall of these emotional episodes may have been associated with increased arousal and activation, the mechanism underlying emotional verbal kinesia paradoxica is unclear.

Entities:  

Mesh:

Year:  2001        PMID: 11160949     DOI: 10.1212/wnl.56.2.159

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

1.  Dopamine modulates the response of the human amygdala: a study in Parkinson's disease.

Authors:  Alessandro Tessitore; Ahmad R Hariri; Francesco Fera; William G Smith; Thomas N Chase; Thomas M Hyde; Daniel R Weinberger; Venkata S Mattay
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

2.  Effects of a Cycling Dual Task on Emotional Word Choice in Parkinson's Disease.

Authors:  Audrey A Hazamy; Sara A Horne; Michael S Okun; Chris J Hass; Lori J P Altmann
Journal:  J Speech Lang Hear Res       Date:  2019-06-06       Impact factor: 2.297

3.  Increased anxiety-like behavior following circuit-specific catecholamine denervation in mice.

Authors:  Sara Ferrazzo; Ozge Gunduz-Cinar; Nadia Stefanova; Gabrielle A Pollack; Andrew Holmes; Claudia Schmuckermair; Francesco Ferraguti
Journal:  Neurobiol Dis       Date:  2019-01-21       Impact factor: 5.996

4.  Parkinson's Disease and Politeness.

Authors:  Thomas Holtgraves; Patrick McNamara
Journal:  J Lang Soc Psychol       Date:  2010-06-01

5.  Recognition of emotions from visual and prosodic cues in Parkinson's disease.

Authors:  Alessandra Ariatti; Francesca Benuzzi; Paolo Nichelli
Journal:  Neurol Sci       Date:  2008-09-20       Impact factor: 3.307

6.  The Impact of Clinical and Cognitive Variables on Social Functioning in Parkinson's Disease: Patient versus Examiner Estimates.

Authors:  Patrick McNamara; Karina Stavitsky; Raymon Durso; Erica Harris
Journal:  Parkinsons Dis       Date:  2010-03-11

7.  Motivational Modulation of Self-Initiated and Externally Triggered Movement Speed Induced by Threat of Shock: Experimental Evidence for Paradoxical Kinesis in Parkinson's Disease.

Authors:  Louise M McDonald; Harry J Griffin; Aikaterini Angeli; Mariam Torkamani; Dejan Georgiev; Marjan Jahanshahi
Journal:  PLoS One       Date:  2015-08-18       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.